Click for best price
Diabetic Gastroparesis Drugs Market Size, Share 2022
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
This report contains market size and forecasts of Diabetic Gastroparesis Drugs in Global, including the following market information:
Global Diabetic Gastroparesis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetic Gastroparesis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prokinetic Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetic Gastroparesis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Gastroparesis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, by Type, 2021 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Diabetic Gastroparesis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Diabetic Gastroparesis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Gastroparesis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetic Gastroparesis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Diabetic Gastroparesis Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetic Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Gastroparesis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetic Gastroparesis Drugs Overall Market Size
2.1 Global Diabetic Gastroparesis Drugs Market Size: 2021 VS 2028
2.2 Global Diabetic Gastroparesis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetic Gastroparesis Drugs Players in Global Market
3.2 Top Global Diabetic Gastroparesis Drugs Companies Ranked by Revenue
3.3 Global Diabetic Gastroparesis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Gastroparesis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Gastroparesis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Diabetic Gastroparesis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Diabetic Gastroparesis Drugs Market Size Markets, 2021 & 2028
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetic Gastroparesis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Diabetic Gastroparesis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetic Gastroparesis Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetic Gastroparesis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Diabetic Gastroparesis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Diabetic Gastroparesis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetic Gastroparesis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Diabetic Gastroparesis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.3.2 US Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.3.3 Canada Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.3.4 Mexico Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.4.2 Germany Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.3 France Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.4 U.K. Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.5 Italy Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.6 Russia Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.8 Benelux Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.5.2 China Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.3 Japan Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.4 South Korea Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.6 India Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.6.2 Brazil Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.6.3 Argentina Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.7.2 Turkey Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7.3 Israel Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7.5 UAE Diabetic Gastroparesis Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Sumitomo
7.1.1 Sumitomo Corporate Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Diabetic Gastroparesis Drugs Major Product Offerings
7.1.4 Sumitomo Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.1.5 Sumitomo Key News
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Corporate Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.2.5 Cadila Pharmaceuticals Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Diabetic Gastroparesis Drugs Major Product Offerings
7.3.4 Sanofi Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Diabetic Gastroparesis Drugs Major Product Offerings
7.4.4 Teva Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Diabetic Gastroparesis Drugs Major Product Offerings
7.5.4 Johnson & Johnson Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Diabetic Gastroparesis Drugs Major Product Offerings
7.6.4 Pfizer Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Corporate Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.7.4 Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.7.5 Kyowa Kirin Pharmaceuticals Key News
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Corporate Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Diabetic Gastroparesis Drugs Major Product Offerings
7.8.4 Hanmi Pharm Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.8.5 Hanmi Pharm Key News
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Corporate Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.9.4 Ani Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.9.5 Ani Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetic Gastroparesis Drugs Market Opportunities & Trends in Global Market
Table 2. Diabetic Gastroparesis Drugs Market Drivers in Global Market
Table 3. Diabetic Gastroparesis Drugs Market Restraints in Global Market
Table 4. Key Players of Diabetic Gastroparesis Drugs in Global Market
Table 5. Top Diabetic Gastroparesis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Gastroparesis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Gastroparesis Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Gastroparesis Drugs Product Type
Table 9. List of Global Tier 1 Diabetic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Gastroparesis Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Gastroparesis Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Sumitomo Corporate Summary
Table 31. Sumitomo Diabetic Gastroparesis Drugs Product Offerings
Table 32. Sumitomo Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Cadila Pharmaceuticals Corporate Summary
Table 34. Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Product Offerings
Table 35. Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Diabetic Gastroparesis Drugs Product Offerings
Table 38. Sanofi Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Diabetic Gastroparesis Drugs Product Offerings
Table 41. Teva Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Diabetic Gastroparesis Drugs Product Offerings
Table 44. Johnson & Johnson Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Diabetic Gastroparesis Drugs Product Offerings
Table 47. Pfizer Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Kyowa Kirin Pharmaceuticals Corporate Summary
Table 49. Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Product Offerings
Table 50. Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Hanmi Pharm Corporate Summary
Table 52. Hanmi Pharm Diabetic Gastroparesis Drugs Product Offerings
Table 53. Hanmi Pharm Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Ani Pharmaceuticals Corporate Summary
Table 55. Ani Pharmaceuticals Diabetic Gastroparesis Drugs Product Offerings
Table 56. Ani Pharmaceuticals Diabetic Gastroparesis Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Diabetic Gastroparesis Drugs Segment by Type in 2021
Figure 2. Diabetic Gastroparesis Drugs Segment by Application in 2021
Figure 3. Global Diabetic Gastroparesis Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Gastroparesis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Gastroparesis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Gastroparesis Drugs Revenue in 2021
Figure 8. By Type - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 12. US Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 24. China Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Sumitomo Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hanmi Pharm Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ani Pharmaceuticals Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
